SI1890705T1 - Uporaba 24-nor-UDCA za zdravljenje holestatskih bolezni jeter - Google Patents

Uporaba 24-nor-UDCA za zdravljenje holestatskih bolezni jeter

Info

Publication number: SI1890705T1
Authority: SI; Slovenia
Prior art keywords: udca; treatment; liver diseases; cholestatic liver; cholestatic
Prior art date: 2005-05-12

Application number

SI200532036T

Other languages

English (en)

Inventor

Michael Trauner

Alan Hofmann

Peter Fickert

Original Assignee

Medizinische Universitaet Graz

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-05-12

Filing date

2005-05-12

Publication date

2016-02-29

2005-05-12 Application filed by Medizinische Universitaet Graz filed Critical Medizinische Universitaet Graz

2016-02-29 Publication of SI1890705T1 publication Critical patent/SI1890705T1/sl

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Ultra Sonic Daignosis Equipment (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Oscillators With Electromechanical Resonators (AREA)
Medicines Containing Plant Substances (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

SI200532036T 2005-05-12 2005-05-12 Uporaba 24-nor-UDCA za zdravljenje holestatskih bolezni jeter SI1890705T1 (sl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP05749537.6A EP1890705B1 (en)	2005-05-12	2005-05-12	Use of 24-nor-UDCA for the treatment of cholestatic liver diseases
PCT/EP2005/052178 WO2006119803A1 (en)	2005-05-12	2005-05-12	USE OF 24-nor-UDCA

Publications (1)

Publication Number	Publication Date
SI1890705T1 true SI1890705T1 (sl)	2016-02-29

Family

ID=35457032

Family Applications (4)

Application Number	Title	Priority Date	Filing Date
SI200532003T SI2392337T1 (sl)	2005-05-12	2005-05-12	Uporaba 24-norUDCA
SI200532092A SI2392336T1 (sl)	2005-05-12	2005-05-12	24-norUDCA za zdravljenje avtoimunskega hepatitisa
SI200531997T SI2392335T1 (sl)	2005-05-12	2005-05-12	Uporaba 24-norUDCA
SI200532036T SI1890705T1 (sl)	2005-05-12	2005-05-12	Uporaba 24-nor-UDCA za zdravljenje holestatskih bolezni jeter

Family Applications Before (3)

Application Number	Title	Priority Date	Filing Date
SI200532003T SI2392337T1 (sl)	2005-05-12	2005-05-12	Uporaba 24-norUDCA
SI200532092A SI2392336T1 (sl)	2005-05-12	2005-05-12	24-norUDCA za zdravljenje avtoimunskega hepatitisa
SI200531997T SI2392335T1 (sl)	2005-05-12	2005-05-12	Uporaba 24-norUDCA

Country Status (18)

Country	Link
US (1)	US8951995B2 (sl)
EP (4)	EP2392336B1 (sl)
AU (1)	AU2005331734B2 (sl)
CY (4)	CY1116831T1 (sl)
DK (4)	DK2392336T3 (sl)
EA (1)	EA014077B1 (sl)
ES (4)	ES2547127T3 (sl)
HK (1)	HK1161122A1 (sl)
HR (3)	HRP20150949T1 (sl)
HU (4)	HUE025184T2 (sl)
LT (1)	LT2392336T (sl)
ME (3)	ME02544B (sl)
NO (1)	NO340318B1 (sl)
PL (4)	PL2392336T3 (sl)
PT (3)	PT2392335E (sl)
RS (3)	RS55180B1 (sl)
SI (4)	SI2392337T1 (sl)
WO (1)	WO2006119803A1 (sl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20080275030A1 (en)	2007-01-19	2008-11-06	Sveinbjorn Gizurarson	Methods and Compositions for the Delivery of a Therapeutic Agent
TR201901012T4 (tr) *	2007-07-25	2019-02-21	Univ Graz Medizinische	Arteriosklerozun tedavisinde nor-safra asitlerinin kullanımı.
EP2468762A1 (en) *	2010-11-30	2012-06-27	Dr. Falk Pharma Gmbh	Optimized synthesis of pure, non-polymorphic, crystalline bile acids with defined particle size
EP3461485A1 (en)	2017-09-28	2019-04-03	Dr. Falk Pharma Gmbh	Use of nor-ursodeoxycholic acid for reducing liver fat
GB201911821D0 (en)	2019-08-16	2019-10-02	Provost Fellows Found Scholars And The Other Members Of Board Of The College Of The Holy And Undivid	Compounds for use in the treatment of liver disease
US11372809B2 (en) *	2019-09-27	2022-06-28	Oracle International Corporation	System and method for providing correlated content organization in an enterprise content management system based on a training set
WO2021130232A1 (en)	2019-12-23	2021-07-01	Medizinische Universität Wien	Bile acid derivatives in the medical intervention of anxieties and/or stress symptoms
WO2024023669A1 (en) *	2022-07-25	2024-02-01	Shilpa Medicare Limited	Pharmaceutical compositions of nor-udca

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4892868A (en)	1984-08-17	1990-01-09	Gipharmex, S.P.A.	Derivatives of biliary acids, process for the production thereof and corresponding pharmaceutical compositions
IT1229569B (it) *	1989-04-17	1991-09-04	Giuliani Spa	Derivati di acidi biliari, loro preparazione e composizioni farmaceutiche che li contengono.
IT1255449B (it)	1992-06-30	1995-10-31	Fabio Berlati	Uso di nor- e omo-derivati di acidi biliari come promotori di assorbimento di farmaci.
TW289020B (sl)	1993-05-08	1996-10-21	Hoechst Sktiengesellschaft
ITMI20012572A1 (it)	2001-12-06	2003-06-06	Istituto Biochimico Italiano	Microgranuli di acido ursodesossicolico

2005
- 2005-05-12 ME MEP-2016-228A patent/ME02544B/me unknown
- 2005-05-12 PL PL11176271.2T patent/PL2392336T3/pl unknown
- 2005-05-12 ES ES11176270.4T patent/ES2547127T3/es active Active
- 2005-05-12 EA EA200702336A patent/EA014077B1/ru not_active IP Right Cessation
- 2005-05-12 EP EP11176271.2A patent/EP2392336B1/en active Active
- 2005-05-12 SI SI200532003T patent/SI2392337T1/sl unknown
- 2005-05-12 DK DK11176271.2T patent/DK2392336T3/en active
- 2005-05-12 ES ES11176272.0T patent/ES2550204T3/es active Active
- 2005-05-12 AU AU2005331734A patent/AU2005331734B2/en not_active Ceased
- 2005-05-12 PT PT111762704T patent/PT2392335E/pt unknown
- 2005-05-12 LT LTEP11176271.2T patent/LT2392336T/lt unknown
- 2005-05-12 ME MEP-2015-495A patent/ME02737B/me unknown
- 2005-05-12 PL PL11176272T patent/PL2392337T3/pl unknown
- 2005-05-12 RS RS20160771A patent/RS55180B1/sr unknown
- 2005-05-12 EP EP05749537.6A patent/EP1890705B1/en active Active
- 2005-05-12 WO PCT/EP2005/052178 patent/WO2006119803A1/en active Application Filing
- 2005-05-12 PL PL05749537T patent/PL1890705T3/pl unknown
- 2005-05-12 US US11/914,211 patent/US8951995B2/en active Active
- 2005-05-12 SI SI200532092A patent/SI2392336T1/sl unknown
- 2005-05-12 EP EP11176270.4A patent/EP2392335B1/en active Active
- 2005-05-12 RS RS20150511A patent/RS54185B1/en unknown
- 2005-05-12 DK DK11176270.4T patent/DK2392335T3/da active
- 2005-05-12 HU HUE11176270A patent/HUE025184T2/en unknown
- 2005-05-12 PL PL11176270T patent/PL2392335T3/pl unknown
- 2005-05-12 SI SI200531997T patent/SI2392335T1/sl unknown
- 2005-05-12 EP EP11176272.0A patent/EP2392337B1/en active Active
- 2005-05-12 SI SI200532036T patent/SI1890705T1/sl unknown
- 2005-05-12 ME MEP-2016-198A patent/ME02256B/me unknown
- 2005-05-12 DK DK11176272.0T patent/DK2392337T3/en active
- 2005-05-12 DK DK05749537.6T patent/DK1890705T3/en active
- 2005-05-12 HU HUE11176272A patent/HUE025409T2/en unknown
- 2005-05-12 HU HUE05749537A patent/HUE028336T2/en unknown
- 2005-05-12 HU HUE11176271A patent/HUE030010T2/en unknown
- 2005-05-12 ES ES05749537.6T patent/ES2561614T3/es active Active
- 2005-05-12 ES ES11176271.2T patent/ES2590333T3/es active Active
- 2005-05-12 RS RS20150495A patent/RS54140B1/en unknown
- 2005-05-12 PT PT111762712T patent/PT2392336T/pt unknown
- 2005-05-12 PT PT111762720T patent/PT2392337E/pt unknown
2007
- 2007-12-12 NO NO20076405A patent/NO340318B1/no not_active IP Right Cessation
2012
- 2012-02-24 HK HK12101926.3A patent/HK1161122A1/xx not_active IP Right Cessation
2015
- 2015-09-08 HR HRP20150949TT patent/HRP20150949T1/hr unknown
- 2015-09-23 CY CY20151100834T patent/CY1116831T1/el unknown
- 2015-10-16 HR HRP20151091TT patent/HRP20151091T1/hr unknown
- 2015-10-21 CY CY20151100939T patent/CY1116840T1/el unknown
2016
- 2016-02-10 CY CY20161100107T patent/CY1117174T1/el unknown
- 2016-09-02 CY CY20161100863T patent/CY1117959T1/el unknown
- 2016-09-19 HR HRP20161197TT patent/HRP20161197T1/hr unknown

Also Published As

Publication number	Publication date
EP2392335A2 (en)	2011-12-07
CY1116831T1 (el)	2017-03-15
PT2392337E (pt)	2015-11-02
EP2392336B1 (en)	2016-06-22
CY1117174T1 (el)	2017-04-05
NO20076405L (no)	2008-02-11
HUE025184T2 (en)	2016-01-28
US8951995B2 (en)	2015-02-10
EP2392337B1 (en)	2015-07-29
WO2006119803A1 (en)	2006-11-16
EA014077B1 (ru)	2010-08-30
EP2392335B1 (en)	2015-06-24
RS54185B1 (en)	2015-12-31
SI2392337T1 (sl)	2015-10-30
ME02544B (me)	2017-02-20
EP1890705A1 (en)	2008-02-27
EP2392336A2 (en)	2011-12-07
AU2005331734A1 (en)	2006-11-16
ES2590333T3 (es)	2016-11-21
SI2392336T1 (sl)	2016-10-28
EA200702336A1 (ru)	2008-04-28
HRP20161197T1 (hr)	2016-11-04
ES2561614T3 (es)	2016-02-29
EP1890705B1 (en)	2015-11-11
EP2392336A3 (en)	2011-12-28
DK2392337T3 (en)	2015-09-28
CY1117959T1 (el)	2017-05-17
CY1116840T1 (el)	2017-03-15
ES2550204T3 (es)	2015-11-05
EP2392337A2 (en)	2011-12-07
HUE030010T2 (en)	2017-04-28
HRP20150949T1 (hr)	2015-12-04
ME02737B (me)	2015-12-31
NO340318B1 (no)	2017-03-27
HUE025409T2 (en)	2016-02-29
PL2392336T3 (pl)	2016-12-30
EP2392337A3 (en)	2012-01-04
ME02256B (me)	2015-12-31
SI2392335T1 (sl)	2015-10-30
HK1161122A1 (en)	2012-08-24
PT2392336T (pt)	2016-10-04
RS54140B1 (en)	2015-12-31
DK2392335T3 (en)	2015-06-29
US20090163459A1 (en)	2009-06-25
EP2392335A3 (en)	2011-12-28
PT2392335E (pt)	2015-10-06
PL2392337T3 (pl)	2015-12-31
AU2005331734B2 (en)	2012-04-19
LT2392336T (lt)	2016-10-10
HRP20151091T1 (hr)	2015-11-06
PL2392335T3 (pl)	2015-10-30
DK1890705T3 (en)	2016-02-01
PL1890705T3 (pl)	2016-05-31
ES2547127T3 (es)	2015-10-01
DK2392336T3 (en)	2016-09-05
HUE028336T2 (en)	2016-12-28
RS55180B1 (sr)	2017-01-31

Publication	Publication Date	Title
HK1131141A1 (en)	2010-01-15	Imidazolothiazole compounds for the treatment of disease
HUE054365T2 (hu)	2021-09-28	Bór-ftalidok terápiás alkalmazásra
ZA200707591B (en)	2009-08-26	Dihyrothienopyrimidines for the treatment of inflammatory diseases
EP1928453A4 (en)	2012-11-28	METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING RENAL DISEASES
GB0621452D0 (en)	2006-12-06	Therapy for liver disease
IL184934A0 (en)	2007-12-03	4-oxoquinazoline-3-yl-benzamide derivatives for the treatment of cytokine diseases
IL193747A0 (en)	2009-08-03	New therapeutic combinations for the treatment of depression
IL196202A0 (en)	2009-09-22	Indazole derivatives for the treatment of hsp90-induced diseases
EP1755615A4 (en)	2009-07-29	TREATMENT OF SUPPORT FOR LIVER DISEASE
PL1890705T3 (pl)	2016-05-31	Zastosowanie 24-nor-UDCA do leczenia cholestatycznych chorób wątroby
HK1104235A1 (en)	2008-01-11	S-mirtazapine for the treatment of hot flush
EP1885384A4 (en)	2012-04-11	TREATMENT OF LIVER DISEASES
HU0500145D0 (en)	2005-04-28	Composition for the treatment of oral diseases
GB0620695D0 (en)	2006-11-29	Composition and methods for the treatment of nurdegenerative disease
IL187792A0 (en)	2008-11-03	4-anilino-3-quinolinecarbonitriles for the treatment of cancer
EP1865952A4 (en)	2009-11-04	COMPOSITIONS CONTAINING HISTAMINES FOR THE TREATMENT OF ALLERGIES
PL1904060T3 (pl)	2011-12-30	Zastosowanie pochodnych ftalocyjaniny do nie-fotodynamicznego leczenia chorób
GB0400802D0 (en)	2004-02-18	Compounds for the treatment of disease
ZA200804266B (en)	2009-01-28	Therapeutic uses of steroidal compounds
IL190182A0 (en)	2008-11-03	2-aminoalcohols for the treatment of neurodegenerative diseases
ZA200805522B (en)	2009-04-29	Dioxoiane dérivates for the treatment of cancer
ZA200606780B (en)	2008-08-27	Compounds for the treatment of diseases
IL177531A0 (en)	2006-12-10	Compounds for the treatment of diseases
GB0425073D0 (en)	2004-12-15	Compounds for the treatment of diseases
GB0420867D0 (en)	2004-10-20	Compounds for the treatment of diseases